Concept:
HAT medium stands for:
\[
\text{HAT} = \text{Hypoxanthine} + \text{Aminopterin} + \text{Thymidine}
\]
It is commonly used in hybridoma technology for the selection of hybrid cells.
Aminopterin is a folic acid analogue that inhibits the enzyme dihydrofolate reductase (DHFR), thereby blocking the de novo synthesis of nucleotides.
As a result, cells are forced to use the salvage pathway for DNA synthesis.
Step 1: Understanding the role of aminopterin in HAT medium.
Aminopterin inhibits:
\[
\text{Dihydrofolate reductase (DHFR)}
\]
This prevents the formation of tetrahydrofolate required for:
\[
\textit{de novo} \text{ nucleotide synthesis}
\]
Hence:
\[
\boxed{\text{Aminopterin blocks the } \textit{de novo} \text{ pathway of nucleotide synthesis}}
\]
Step 2: Importance of the salvage pathway in HAT medium.
Since the de novo pathway is blocked, cells survive only if they can utilize:
\[
\text{Salvage pathway}
\]
Hypoxanthine and thymidine present in HAT medium help cells synthesize nucleotides through the salvage pathway.
Step 3: Eliminating the incorrect options.
• Option (B): Aminopterin inhibits rather than activates the de novo pathway.
• Option (C): Aminopterin does not block the salvage pathway.
• Option (D): Aminopterin itself does not activate the salvage pathway; it indirectly forces cells to depend on it.
Therefore, option (A) is correct.